Clinical Trial Update: Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma [Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 2 study evaluating the combination of sunitinib, temozolomide, and radiation therapy for glioblastoma. The current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Sunitinib (sunitinib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Bassam Abdulkarim | Conditions: Glioblastoma Multiforme | Phase 2 | Status: UNKNOWN